Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
DNA damage
Biotech
Rakovina deepens AI focus with collab to select cancer targets
The financial details were left vague, but we do know that Rakovina will pay a “low upfront fee” to begin work on each selected target.
James Waldron
Sep 17, 2024 9:20am
Don't junk DNA as study shows new role in brain disease
Sep 30, 2022 3:25pm
Fighting drug-resistant cancer by blocking an escape route
Jan 5, 2022 8:35am
How strange DNA structures could inspire new cancer drugs
Dec 29, 2021 4:34am
Injured tumor cells activate I-O drugs in cancer models
Oct 19, 2021 2:00pm
Zai Lab to pay Schrödinger up to $338M in cancer R&D biobucks
Aug 4, 2021 10:32am
